Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19.

Détails

Ressource 1Télécharger: 32300051_BIB_819D81E8FA74.pdf (404.41 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC 4.0
ID Serval
serval:BIB_819D81E8FA74
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Editorial
Collection
Publications
Institution
Titre
Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19.
Périodique
Journal for immunotherapy of cancer
Auteur(s)
Ascierto P.A., Fox B., Urba W., Anderson A.C., Atkins M.B., Borden E.C., Brahmer J., Butterfield L.H., Cesano A., Chen D., de Gruijl T., Dillman R.O., Drake C.G., Emens L.A., Gajewski T.F., Gulley J.L., Stephen Hodi F., Hwu P., Kaufman D., Kaufman H., Lotze M., McNeel D.G., Margolin K., Marincola F., Mastrangelo M.J., Maus M.V., Parkinson D.R., Romero P.J., Sondel P.M., Spranger S., Sznol M., Weiner G.J., Wiggington J.M., Weber J.S.
ISSN
2051-1426 (Electronic)
ISSN-L
2051-1426
Statut éditorial
Publié
Date de publication
04/2020
Peer-reviewed
Oui
Volume
8
Numéro
1
Langue
anglais
Notes
Publication types: Editorial
Publication Status: ppublish
Mots-clé
Betacoronavirus, Coronavirus Infections/diagnostic imaging, Coronavirus Infections/drug therapy, Coronavirus Infections/immunology, Coronavirus Infections/therapy, Drug Approval, Humans, Immunologic Factors/therapeutic use, Immunotherapy, Inflammation/blood, Inflammation/therapy, Interleukin-6/agonists, Neoplasms/therapy, Pandemics, Pneumonia, Viral/diagnostic imaging, Pneumonia, Viral/drug therapy, Pneumonia, Viral/immunology, Pneumonia, Viral/therapy, Receptors, Interleukin-6/agonists, immunomodulation, inflammation mediators
Pubmed
Open Access
Oui
Création de la notice
25/04/2020 19:59
Dernière modification de la notice
15/01/2021 8:10
Données d'usage